BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.44
-0.62 (-3.43%)
At close: Apr 28, 2026, 4:00 PM EDT
17.36
-0.08 (-0.46%)
Pre-market: Apr 29, 2026, 8:39 AM EDT
BioAge Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 9 | - | - | - |
| Cost of Revenue | 73.97 | 59.04 | 33.89 | - |
| Gross Profit | -64.97 | -59.04 | -33.89 | - |
| Selling, General & Admin | 27.81 | 19.16 | 14.51 | 9.45 |
| Research & Development | - | - | - | 30.52 |
| Operating Expenses | 27.81 | 19.16 | 14.51 | 39.97 |
| Operating Income | -92.78 | -78.19 | -48.4 | -39.97 |
| Interest Expense | -0.7 | -2.37 | -7.79 | -0.24 |
| Interest & Investment Income | 13.09 | 9.63 | 2.43 | 0.47 |
| Other Non Operating Income (Expenses) | -0.21 | 0.07 | - | - |
| EBT Excluding Unusual Items | -80.61 | -70.86 | -53.76 | -39.75 |
| Other Unusual Items | - | -0.25 | -10.09 | 0.02 |
| Pretax Income | -80.61 | -71.11 | -63.85 | -39.72 |
| Net Income | -80.61 | -71.11 | -63.85 | -39.72 |
| Net Income to Common | -80.61 | -71.11 | -63.85 | -39.72 |
| Shares Outstanding (Basic) | 36 | 11 | 2 | 2 |
| Shares Outstanding (Diluted) | 36 | 11 | 2 | 2 |
| Shares Change (YoY) | 234.99% | 541.23% | 0.06% | - |
| EPS (Basic) | -2.24 | -6.63 | -38.17 | -23.76 |
| EPS (Diluted) | -2.24 | -6.63 | -38.17 | -23.76 |
| Free Cash Flow | -82.35 | -51.89 | -37.53 | -36.28 |
| Free Cash Flow Per Share | -2.29 | -4.84 | -22.43 | -21.70 |
| Operating Margin | -1031.46% | - | - | - |
| Profit Margin | -896.11% | - | - | - |
| Free Cash Flow Margin | -915.46% | - | - | - |
| EBITDA | -92.57 | -78.03 | -48.24 | -39.84 |
| D&A For EBITDA | 0.21 | 0.17 | 0.16 | 0.13 |
| EBIT | -92.78 | -78.19 | -48.4 | -39.97 |
Source: S&P Capital IQ. Standard template.
Financial Sources.